Prolonging Gastrointestinal-Stromal-Tumor-free life, an optimal suggestion of imatinib intervention ahead of operation.

Yan, Lin-Hai; Chen, Zhi-Ning; Li, Chun-Jun; Chen, Jia; Qin, Yu-Zhou; Chen, Jian-Si; Tang, Wei-Zhong

Yan, Lin-Hai; Chen, Zhi-Ning; Li, Chun-Jun; Chen, Jia; Qin, Yu-Zhou; Chen, Jian-Si; Tang, Wei-Zhong.

Affiliation

Yan LH; Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Chen ZN; Department of Pathology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Li CJ; Department of Pathology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Chen J; Department of Medical Image Center, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Qin YZ; Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Chen JS; Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Tang WZ; Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

J Cancer ; 9(21): 3850-3857, 2018.

Article in En | MEDLINE | ID: mdl-30410587

Key words

Cancer-specific survival; Gastrointestinal stromal tumor; Neoadjuvant imatinib; Surgical resection

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Cancer Year: 2018 Document type: Article Affiliation country: China Country of publication: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google